Solventum (NYSE:SOLV – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the ...

Solventum (NYSE:SOLV – Get Free Report) is one of 238 publicly-traded companies in the “Surgical & medical instruments” ...

As of Dec. 31, the company still had $7.81 billion in long-term debt. Solventum sold off its purification and filtration ...

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

Maplewood, Minnesota-based Solventum Corporation (SOLV) is a healthcare company specializing in developing, manufacturing, ...

and Purification and Filtration segments. Companies worth $10 billion or more are generally described as "large-cap stocks," Solventum fits right into that category, reflecting its significant ...

Solventum’s Purification & Filtration business provides purification and filtration technologies for the production of biologics, medical technologies, and industrial applications. Solventum ...

Solventum sold off its purification and filtration business to Thermo Fisher last month for $4.1 billion, and will use the $3.4 billion in net proceeds primarily to pay down debt.

The global Traditional Wound Care Market , valued at US$7.15 billion in 2024, is forecasted to grow at a robust CAGR of 4.2%, ...

Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business ...

Solventum Logo (PRNewsfoto/3M Healthcare US ... The recently announced sale of our Purification & Filtration (P&F) business is a major milestone and will allow us to accelerate our plans and ...